tiprankstipranks
Aubay Société Anonyme (GB:0IPY)
LSE:0IPY
Holding GB:0IPY?
Track your performance easily

Aubay Société Anonyme (0IPY) Income Statement

1 Followers

Aubay Société Anonyme Income Statement

Last quarter (Q4 2022), Aubay Société Anonyme's total revenue was €―, a decrease of ― from the same quarter last year. In Q4, Aubay Société Anonyme's net income was €―. See Aubay Société Anonyme’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
-€ 513.55M€ 471.01M€ 426.80M€ 418.00M€ 400.58M
Cost of Revenue
-€ 363.44M€ 329.68M€ 299.47M€ 364.41M€ 353.61M
Gross Profit
-€ 150.11M€ 141.33M€ 127.33M€ 127.72M€ 46.97M
Operating Expense
-€ 98.55M€ 92.89M€ 87.23M€ 86.40M€ 6.54M
Operating Income
-€ 51.56M€ 48.44M€ 40.10M€ 41.32M€ 40.43M
Net Non Operating Interest Income Expense
-€ -681.00K€ 84.00K€ -419.00K€ -309.00K€ -273.00K
Other Income Expense
------
Pretax Income
-€ 49.40M€ 47.40M€ 38.22M€ 39.54M€ 39.25M
Tax Provision
-€ 13.77M€ 12.92M€ 12.04M€ 13.13M€ 11.92M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-€ 35.63M€ 34.41M€ 26.13M€ 26.41M€ 27.33M
Basic EPS
-€ 2.69-€ 1.98€ 2.00€ 2.08
Diluted EPS
-€ 2.67-€ 1.97€ 1.99€ 2.07
Basic Average Shares
-€ 13.25M-€ 13.19M€ 13.18M€ 13.11M
Diluted Average Shares
-€ 13.33M-€ 13.25M€ 13.27M€ 13.21M
Dividend Per Share
-€ 1.26-€ 0.60€ 0.66€ 0.51
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-€ 461.99M€ 422.57M€ 386.70M€ 376.68M€ 360.15M
Net Income From Continuing And Discontinued Operation
-€ 35.63M€ 34.41M€ 26.13M€ 26.41M€ 27.33M
Normalized Income
-€ 36.69M€ 35.23M€ 27.14M€ 27.39M€ 27.96M
Interest Expense
-€ 681.00K€ 494.00K€ 588.00K€ 725.00K€ 456.00K
EBIT
-€ 50.08M€ 47.90M€ 38.81M€ 40.27M€ 39.70M
EBITDA
-€ 57.93M€ 55.45M€ 46.44M€ 47.68M€ 41.72M
Currency in EUR

Aubay Société Anonyme Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis